- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Central Nervous System Hodgkin Lymphoma in Netherlands
Total 2387 results
-
UMC UtrechtZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedNon-Hodgkin's Lymphoma | Hodgkin's Disease | Malignant LymphomaNetherlands
-
Radboud University Medical CenterUnknown
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
European Organisation for Research and Treatment...Stichting Hemato-Oncologie voor Volwassenen Nederland; Lymphoma Trials OfficeTerminated
-
UMC UtrechtStichting Kinderen Kankervrij (KiKa)CompletedHodgkin's LymphomaNetherlands, Austria, Italy, Spain
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
Bristol-Myers SquibbActive, not recruiting
-
Commissie Voor Klinisch Toegepast OnderzoekUnknown
-
European Organisation for Research and Treatment...Fondazione Italiana Linfomi ONLUS; Lymphoma Study AssociationUnknown
-
European Organisation for Research and Treatment...TerminatedLymphomaFrance, Belgium, Denmark, Egypt, Netherlands, Croatia
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Commissie Voor Klinisch Toegepast OnderzoekCompleted
-
Sheba Medical CenterCity of Hope Medical Center; Amsterdam UMC, location VUmc; University of GöttingenCompletedNon-Hodgkin's LymphomaUnited States, Netherlands, Germany, Israel
-
Genzyme, a Sanofi CompanyCompletedTransplantation | Lymphoma (Non-Hodgkin's Lymphoma) | Hodgkin's Disease or Multiple Myeloma | Front Line MobilizationNetherlands, France, Germany, Sweden, Spain, Italy, United Kingdom
-
University of AarhusActive, not recruitingMalignant LymphomaNetherlands, Norway, Denmark, Finland, Sweden
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
European Organisation for Research and Treatment...CompletedLymphomaFrance, Netherlands, Belgium, United Kingdom, Egypt, Switzerland, Portugal
-
University Medical Center GroningenRecruiting
-
Bristol-Myers SquibbCompletedHodgkin DiseaseCanada, United States, Belgium, Austria, Czechia, Germany, Italy, Netherlands, Spain, United Kingdom
-
Centre for Human Drug Research, NetherlandsLeiden University Medical Center; MicreosEnrolling by invitation
-
CelgeneCompletedLymphoma, Non-Hodgkin | Precursor Cell Lymphoblastic Leukemia-LymphomaSpain, Netherlands, United States, France, Germany, Italy
-
St. Antonius HospitalCompletedNon-Hodgkin Lymphoma (NHL)Netherlands
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Canada, Belgium, Poland, Czechia, Italy, France, Germany, Netherlands, Sweden
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
European Organisation for Research and Treatment...Active, not recruitingAdvanced Hodgkin LymphomaBelgium, Spain, Netherlands, Denmark, Poland, Portugal, Slovakia
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic...Netherlands
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupActive, not recruitingPrimary Mediastinal Large B Cell LymphomaFrance, Belgium, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
Bristol-Myers SquibbSeagen Inc.Active, not recruitingHodgkin DiseaseUnited Kingdom, United States, Poland, Spain, Canada, Czechia, France, Germany, Ireland, Italy, Netherlands
-
The Netherlands Cancer InstituteDutch Cancer SocietyCompletedHodgkin Lymphoma | Diffuse Large B Cell LymphomaNetherlands
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hodgkin Lymphoma | Relapsed or Refractory Anaplastic Large-cell LymphomaUnited States, France, United Kingdom, Germany, Spain, Netherlands, Italy, Mexico
-
European Organisation for Research and Treatment...CompletedLymphoma | Small Intestine CancerFrance, Belgium, Egypt, Netherlands, Croatia
-
Bristol-Myers SquibbRecruitingLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, France, Netherlands, Australia, United Kingdom, Italy, Spain, Germany
-
PfizerUCB PharmaCompletedLymphomaUnited States, Belgium, Japan, Korea, Republic of, Germany, Hong Kong, Hungary, Netherlands, Singapore
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Centre for Human Drug Research, NetherlandsRecordati Rare DiseasesCompleted
-
Mundipharma Research LimitedActive, not recruitingMultiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell LymphomaFrance, United States, Netherlands, Spain, Switzerland, Germany, Italy
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
University of GiessenDeutsche Krebshilfe e.V., Bonn (Germany); Euronet WorldwideActive, not recruitingClassical Hodgkin LymphomaUnited Kingdom, Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Spain, Sweden, Switzerland
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, Netherlands, Canada, France
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Non-Hodgkin's LymphomaHong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
-
University Medical Center GroningenHoffmann-La Roche; Amsterdam UMC, location VUmc; Stichting Hemato-Oncologie voor...WithdrawnDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedNetherlands
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDanish Lymphoma GroupRecruitingHodgkin LymphomaNetherlands, Belgium, Denmark
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaBelgium, Italy, Spain, United States, Canada, Sweden, Greece, Netherlands, Austria, Switzerland, Poland, Turkey, Croatia, Brazil, Argentina, Denmark, United Kingdom